| Gene symbol | TNFRSF17 | Synonyms | BCM, BCMA, CD269, TNFRSF13A | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p13.13 | dbXrefs | |
| Description | TNF receptor superfamily member 17 | ||||
| GTO ID | GTC0928 |
| Trial ID | ChiCTR2100046438 |
| Disease | Multiple Myeloma |
| Altered gene | BCMA |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | Ori-CAR-002 T infusion |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | Ori-CAR-002 Chimeric Antigen Receptor T Cell Therapy for Relapsed/Refractory Multiple Myeloma with Failure of Standard Therapy: a Single-Arm, Open Clinical Trial |
| Year | 2021 |
| Country | China |
| Company sponsor | Renji Hospital, Shanghai Jiaotong University School of Medicine |
| Cohort 1 | |||||||||
|
|||||||||